Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Folia Histochemica Et Cytobiologica|April 29, 2011
CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphomaIwona Hus, Elżbieta Starosławska, Agnieszka Bojarska-Junak, et al.
Pharmacological Reports : PR|April 20, 2019
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysisMonika Długosz-Danecka, Iwona Hus, Bartosz Puła, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Polish Archives of Internal Medicine|July 31, 2018
Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities - Polish Adult Leukemia Group (PALG) real-life analysisMonika Długosz-Danecka, Wojciech Jurczak, Ewa Łątka-Cabała, et al.
Leukemia Research|July 15, 2010
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study GroupAnna Dmoszynska, Adam Walter-Croneck, Iwona Hus, et al.
Polish Archives of Internal Medicine|September 15, 2017
Real‑life experience with bortezomib‑based regimens in elderly patients with newly diagnosed multiple myeloma and comorbidities: a Polish retrospective multicenter studyIwona Hus, Adam Walter-Croneck, Anna Masternak, et al.
Cancer Medicine|October 7, 2022
Secondary malignancies and survival of FCR-treated patients with chronic lymphocytic leukemia in Central EuropeFruzsina Kósa, Tereza Nečasová, Martin Špaček, et al.
Cells|April 26, 2024
High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib DiscontinuationPaulina Kwaśnik, Joanna Zaleska, Dorota Link-Lenczowska, et al.
International Journal of Cancer|January 24, 2023
Molnupiravir is effective in patients with haematological malignanciesŁukasz Bołkun, Bartosz Pula, Agnieszka Kołkowska-Leśniak, et al.
Chemotherapy|March 6, 2022
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research GroupEwa Paszkiewicz-Kozik, Malgorzata Debowska, Natalia Jakacka, et al.
Pageof 8